257 related articles for article (PubMed ID: 18095050)
1. Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening.
Conrad DH; Goyette J; Thomas PS
J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):78-84. PubMed ID: 18095050
[TBL] [Abstract][Full Text] [Related]
2. Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers.
Hayes SA; Haefliger S; Harris B; Pavlakis N; Clarke SJ; Molloy MP; Howell VM
J Breath Res; 2016 Jul; 10(3):034001. PubMed ID: 27380020
[TBL] [Abstract][Full Text] [Related]
3. Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics.
López-Sánchez LM; Jurado-Gámez B; Feu-Collado N; Valverde A; Cañas A; Fernández-Rueda JL; Aranda E; Rodríguez-Ariza A
Am J Physiol Lung Cell Mol Physiol; 2017 Oct; 313(4):L664-L676. PubMed ID: 28619761
[TBL] [Abstract][Full Text] [Related]
4. Proteomics of exhaled breath condensate in lung cancer and controls using data-independent acquisition (DIA): a pilot study.
Ma L; Muscat JE; Sinha R; Sun D; Xiu G
J Breath Res; 2021 Jan; 15(2):. PubMed ID: 33271515
[TBL] [Abstract][Full Text] [Related]
5. CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer.
Zou Y; Wang L; Zhao C; Hu Y; Xu S; Ying K; Wang P; Chen X
J Breath Res; 2013 Dec; 7(4):047101. PubMed ID: 24185583
[TBL] [Abstract][Full Text] [Related]
6. Mass Spectrometry Analysis of the Exhaled Breath Condensate and Proposal of Dermcidin and S100A9 as Possible Markers for Lung Cancer Prognosis.
Núñez-Naveira L; Mariñas-Pardo LA; Montero-Martínez C
Lung; 2019 Aug; 197(4):523-531. PubMed ID: 31115649
[TBL] [Abstract][Full Text] [Related]
7. Comparative proteomic analysis of exhaled breath condensate between lung adenocarcinoma and CT-detected benign pulmonary nodule patients.
Ma L; Xiu G; Muscat J; Sinha R; Sun D; Xiu G
Cancer Biomark; 2022; 34(2):163-174. PubMed ID: 34334381
[TBL] [Abstract][Full Text] [Related]
8. Proteomics of exhaled breath condensate in stable COPD and non-COPD controls using tandem mass tags (TMTs) quantitative mass spectrometry: A pilot study.
Sun C; Zhou T; Xie G; Fu S; Gao L; Liao J; Wu Y; Wang G
J Proteomics; 2019 Aug; 206():103392. PubMed ID: 31129269
[TBL] [Abstract][Full Text] [Related]
9. Exhaled breath condensate biomarkers for lung cancer.
Campanella A; De Summa S; Tommasi S
J Breath Res; 2019 Aug; 13(4):044002. PubMed ID: 31282387
[TBL] [Abstract][Full Text] [Related]
10. Advances in proteomics methods for the analysis of exhaled breath condensate.
Yoo EJ; Kim JS; Stransky S; Spivack S; Sidoli S
Mass Spectrom Rev; 2024; 43(4):713-722. PubMed ID: 38149478
[TBL] [Abstract][Full Text] [Related]
11. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.
Han W; Wang T; Reilly AA; Keller SM; Spivack SD
Respir Res; 2009 Sep; 10(1):86. PubMed ID: 19781081
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry based proteome profiling of the exhaled breath condensate for lung cancer biomarkers search.
Zakharova N; Kozyr A; Ryabokon AM; Indeykina M; Strelnikova P; Bugrova A; Nikolaev EN; Kononikhin AS
Expert Rev Proteomics; 2021 Aug; 18(8):637-642. PubMed ID: 34477466
[TBL] [Abstract][Full Text] [Related]
13. Proteomic characterization of human exhaled breath condensate.
Lacombe M; Marie-Desvergne C; Combes F; Kraut A; Bruley C; Vandenbrouck Y; Chamel Mossuz V; Couté Y; Brun V
J Breath Res; 2018 Feb; 12(2):021001. PubMed ID: 29189203
[TBL] [Abstract][Full Text] [Related]
14. Exhaled breath analysis: novel approach for early detection of lung cancer.
Chan HP; Lewis C; Thomas PS
Lung Cancer; 2009 Feb; 63(2):164-8. PubMed ID: 18599152
[TBL] [Abstract][Full Text] [Related]
15. Exhaled breath condensate: a promising source for biomarkers of lung disease.
Liang Y; Yeligar SM; Brown LA
ScientificWorldJournal; 2012; 2012():217518. PubMed ID: 23365513
[TBL] [Abstract][Full Text] [Related]
16. A clinical proteomics study of exhaled breath condensate and biomarkers for pulmonary embolism.
Gade IL; Riddersholm SJ; Stilling-Vinther T; Brøndum RF; Bennike TB; Honoré B
J Breath Res; 2023 Nov; 18(1):. PubMed ID: 37939397
[TBL] [Abstract][Full Text] [Related]
17. Epidermal Growth Factor in Exhaled Breath Condensate as Diagnostic Method for Non-Small Cell Lung Cancer.
Chen J; Chen J; Lv X; Yang Q; Yao S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819872271. PubMed ID: 31495334
[TBL] [Abstract][Full Text] [Related]
18. Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers-A mini-review.
Youssef O; Sarhadi VK; Armengol G; Piirilä P; Knuuttila A; Knuutila S
Genes Chromosomes Cancer; 2016 Dec; 55(12):905-914. PubMed ID: 27480453
[TBL] [Abstract][Full Text] [Related]
19. Exhaled Breath Condensate: An Update.
Davis MD; Montpetit AJ
Immunol Allergy Clin North Am; 2018 Nov; 38(4):667-678. PubMed ID: 30342587
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory markers in exhaled breath condensate following lung resection for bronchial carcinoma.
Jungraithmayr W; Frings C; Zissel G; Prasse A; Passlick B; Stoelben E
Respirology; 2008 Nov; 13(7):1022-7. PubMed ID: 18764914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
